Yamazoe Y, Maetani S, Nishikawa T, Onodera H, Tobe T, Imamura M
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Surg Today. 1994;24(1):30-6. doi: 10.1007/BF01676881.
To assess the prognostic value of DNA ploidy in colorectal cancer, compared with the histopathological findings, paraffin-embedded surgical specimens from 330 patients who underwent resection for primary adenocarcinoma were studied using a new modified method of flow cytometry. Of these specimens, 141 were DNA diploid and 189, DNA aneuploid, among which there were 3 DNA hypodiploid lesions. Of the ten variables studied in curative resection, DNA ploidy ranked fourth in prognostic significance according to the linear trend by the chi 2 test, after nodal status, grade of cellular differentiation, and degree of invasive growth, if the DNA ploidy pattern was classified into three categories. Conversely, DNA ploidy was the sixth most significant factor if DNA hypodiploidy was included in the DNA aneuploidy. The Cox multivariate analysis showed that DNA ploidy was one of the five significant factors independently determining prognosis; however, if adjustment for the modified Dukes' stage was made by the Mantel-Haenszel test, the survival difference between the diploid and aneuploid groups did not reach a statistically significant level. Thus, we conclude that from a practical point of view, DNA ploidy is not an essential factor which must be combined with histopathological variables for a better prediction of patient outcome.
为评估结直肠癌中DNA倍体的预后价值,将330例接受原发性腺癌切除术患者的石蜡包埋手术标本采用一种新的改良流式细胞术方法进行研究,并与组织病理学结果进行比较。在这些标本中,141例为DNA二倍体,189例为DNA非整倍体,其中有3例DNA亚二倍体病变。在根治性切除中研究的10个变量中,若将DNA倍体模式分为三类,根据卡方检验的线性趋势,DNA倍体在预后意义上排名第四,仅次于淋巴结状态、细胞分化程度和浸润生长程度。相反,若将DNA亚二倍体纳入DNA非整倍体中,DNA倍体则是第六个最显著的因素。Cox多变量分析显示,DNA倍体是独立决定预后的五个显著因素之一;然而,若通过Mantel-Haenszel检验对改良的Dukes分期进行校正,二倍体组和非整倍体组之间的生存差异未达到统计学显著水平。因此,我们得出结论,从实际角度来看,DNA倍体不是为更好地预测患者预后而必须与组织病理学变量相结合的关键因素。